Michael A.E. Ramsay, MD, FRCA

Chairman, Department of Anesthesiology and Pain Management, Baylor University Medical Center, and President of Baylor Scott & White Research Institute

Dr. Ramsay is Chairman of the Department of Anesthesiology and Pain Management at Baylor University Medical Center in Dallas, Texas, a position that he has held since 1989.  He is also Co-Medical Director of Operating Room Services.  He serves as a member of the Baylor University Medical Center Board of Trustees and is also a member of the Medical Board.  He is Director of Anesthesia for the liver transplant program and has personally provided anesthesia for over 1,000 liver transplant recipients.  Dr. Ramsay is Past President of the International Liver Transplantation Society.  Dr. Ramsay was recently appointed as an at-large delegate to the United Network for Organ Sharing and is a member of the American Society of Anesthesiologists Committee on Transplant Anesthesia.  He is also a member of the Board of Directors of The Patient Safety Movement Foundation and serves as the Chair of the “Failure to Rescue: Post-operative Respiratory Depression” workgroup.

Dr. Ramsay is a Professor at Texas A & M Health Science Center and holds a clinical professorship in anesthesiology at the University of Texas Southwestern Medical School as well as in the Department of Periodontics at Baylor College of Dentistry, Texas A & M University.

In addition, Dr. Ramsay is the developer of the Ramsay Sedation Scale, a measurement designed for interpreting the depth of sedation for patients in the critical care unit.  This scale has been adopted around the world.  He has published over 200 peer-reviewed articles and numerous chapters in text books.  He was a member of the Sedation Analgesia Guidelines Task Force of the Society of Critical Care Medicine.  This group came out with new guidelines for the management of Pain, Agitation and Delirium in Adult ICU patients in January 2013.

As President of Baylor Scott & White Research Institute (BSWRI), Dr. Ramsay leads clinically relevant research efforts for Baylor Scott & White Health (BSWH).  Since joining the organization, he has developed a successful infrastructure that has increased the number of clinical trials from 250 to more than 2,000 active trials today.  The mission of BRI is expressed in the following statement: “To improve the medical care and well-being of our community – nationally and internationally – through innovative, clinical research that is consistent with the mission, vision and values of Baylor Scott & White Health.”  He executed a multimillion dollar collaboration agreement with La Roche pharmaceuticals that supports very early research projects and accelerates their completion.  This was a pilot project and has now been replicated at many academic centers around the world.

Dr. Ramsay is currently involved in a number of clinical research projects for which he is the principal investigator.  His current research includes the role of nitric oxide in ameliorating the reperfusion injury in liver transplantation.  He also is a Principal Investigator of several NIH-funded clinical trials to improve the outcomes of trauma victims.